Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer

Bohr, 2008, Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance, Trends in biochemical sciences, 33, 609, 10.1016/j.tibs.2008.09.003

Bohr, 2014, Human RecQ helicases in DNA repair, recombination, and replication, Annual review of biochemistry, 83, 519, 10.1146/annurev-biochem-060713-035428

Monnat, 2013, Spectrum and risk of neoplasia in Werner syndrome: a systematic review, PloS one, 8, e59709, 10.1371/journal.pone.0059709

Goto, 2011, Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (Review), Oncology letters, 2, 609, 10.3892/ol.2011.298

von Kobbe, 2007, Role for the Werner syndrome protein in the promotion of tumor cell growth, Mechanisms of ageing and development, 128, 423, 10.1016/j.mad.2007.05.009

Esteller, 2006, Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer, Proceedings of the National Academy of Sciences of the United States of America, 103, 8822, 10.1073/pnas.0600645103

Liu, 1985, Camptothecin induces protein-linked DNA breaksmammalian DNA topoisomerase I, The Journal of biological chemistry, 260, 14873, 10.1016/S0021-9258(17)38654-4

Kaina, 2013, Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors, Biochimica et biophysica acta, 1835, 11

Brosh, 2007, Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges, PloS one, 2, e1297, 10.1371/journal.pone.0001297

Monnat, 2010, The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage, Cancer research, 70, 6548, 10.1158/0008-5472.CAN-10-0475

Matsumoto, 2002, Werner and Bloom helicases are involved in DNA repair in a complementary fashion, Oncogene, 21, 954, 10.1038/sj.onc.1205143

Wang, 2008, Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents, Human genetics, 123, 643, 10.1007/s00439-008-0518-4

Luo, 2009, Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment, Molecular biology of the cell, 20, 114, 10.1091/mbc.e08-06-0565

Bohr, 2014, RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complex, Carcinogenesis, 35, 2415, 10.1093/carcin/bgu137

Luo, 2010, Acetylation of WRN protein regulates its stability by inhibiting ubiquitination, PloS one, 5, e10341, 10.1371/journal.pone.0010341

Guarente, 1998, Nucleolar localization of the Werner syndrome protein in human cells, Proceedings of the National Academy of Sciences of the United States of America, 95, 6887, 10.1073/pnas.95.12.6887

Bohr, 2003, Werner protein stimulates topoisomerase I DNA relaxation activity, Cancer research, 63, 7136

D'Arpa, 1997, Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin, The Journal of biological chemistry, 272, 24159, 10.1074/jbc.272.39.24159

Liu, 2008, A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes, The Journal of biological chemistry, 283, 21074, 10.1074/jbc.M803493200

Ozanne, 2007, DNA damage, cellular senescence and organismal ageing: causal or correlative?, Nucleic acids research, 35, 7417, 10.1093/nar/gkm681

Bohr, 2014, Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice, Cell death & disease, 5, e1226, 10.1038/cddis.2014.168

Monnat, 2003, Werner syndrome protein limits MYC-induced cellular senescence, Genes & development, 17, 1569, 10.1101/gad.1100303

Shen, 2007, Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility, Cancer epidemiology, biomarkers & prevention, 16, 263, 10.1158/1055-9965.EPI-06-0678

Shen, 2009, A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women, Breast cancer research and treatment, 118, 169, 10.1007/s10549-009-0327-z

Hoch, 2013, Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study, Lancet Oncol, 14, 1216, 10.1016/S1470-2045(13)70429-7

Nielsen, 2013, A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer, Breast cancer research and treatment, 138, 347, 10.1007/s10549-013-2476-3

Pommier, 2009, Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity, Molecular cancer therapeutics, 8, 1878, 10.1158/1535-7163.MCT-09-0016

Liu, 2001, Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells, Cancer research, 61, 5926

McKinney, 2012, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983

Yee, 2010, Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy, Cancer biology & therapy, 10, 430, 10.4161/cbt.10.5.12763

Bryant-Greenwood, 2011, The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging, Hawaii medical journal, 70, 52

Brosh, 2011, Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress, Proceedings of the National Academy of Sciences of the United States of America, 108, 1525, 10.1073/pnas.1006423108

Sparreboom, 2001, Modulation of camptothecin analogs in the treatment of cancer: a review, Anticancer Drugs, 12, 89, 10.1097/00001813-200102000-00002

Liu, 1988, Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes, Proceedings of the National Academy of Sciences of the United States of America, 85, 1060, 10.1073/pnas.85.4.1060

Liu, 2000, SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage, Proceedings of the National Academy of Sciences of the United States of America, 97, 4046, 10.1073/pnas.080536597

Cheng, 1995, Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity, Molecular pharmacology, 47, 907

Gong, 2013, TopBP1 controls BLM protein level to maintain genome stability, Molecular cell, 52, 667, 10.1016/j.molcel.2013.10.012

Campisi, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nature cell biology, 11, 973, 10.1038/ncb1909

Wyche, 2002, Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin, The Journal of biological chemistry, 277, 17154, 10.1074/jbc.M112401200

Stenvang, 2015, Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer, Int J Cancer

Gibson, 2015, A review of the evolution of systemic chemotherapy in the management of colorectal cancer, Clin Colorectal Cancer, 14, 1, 10.1016/j.clcc.2014.11.002

Clark, 2005, Reporting recommendations for tumor marker prognostic studies (REMARK), J Natl Cancer Inst, 97, 1180, 10.1093/jnci/dji237

Madhusudan, 2015, Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer, Molecular cancer therapeutics, 14, 1057, 10.1158/1535-7163.MCT-14-0939